Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Villa

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Antiviral Research|December 3, 2014
Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort studySavino Bruno, Alex J Thompson, Rosina Critelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 3, 2019
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control studyStefano Gitto, Francesco Vizzutti, Filippo Schepis, et al.
Biomedicines|July 27, 2024
Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to SexSimone Lasagni, Rosina Maria Critelli, Fabiola Milosa, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 11, 2002
Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantationAntonella Grottola, Paola Buttafoco, Maria Grazia Del Buono, et al.
Infection|November 4, 2017
Current and future challenges in HCV: insights from an Italian experts panelMassimo Andreoni, Sergio Babudieri, Savino Bruno, et al.
Journal of Hepatology|January 15, 2018
Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosisLaura Turco, Guadalupe Garcia-Tsao, Ilenia Magnani, et al.
Stem Cell Research & Therapy|February 22, 2023
Flow-dependent shear stress affects the biological properties of pericyte-like cells isolated from human dental pulpGiulia Bertani, Rosanna Di Tinco, Laura Bertoni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 26, 2020
HCV cirrhotic patients treated with direct-acting antivirals: Detection of tubular dysfunction and resolution after viral clearanceElisa Biliotti, Donatella Palazzo, Francesca Tinti, et al.
Critical Reviews in Oncology/Hematology|December 26, 2024
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantationLorenza Di Marco, Adriana Romanzi, Alessandra Pivetti, et al.
Hepatology Communications|September 14, 2023
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective studyErica Villa, Rossella Donghia, Valentina Baldaccini, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Antiviral Research|December 3, 2014
Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort studySavino Bruno, Alex J Thompson, Rosina Critelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 3, 2019
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control studyStefano Gitto, Francesco Vizzutti, Filippo Schepis, et al.
Biomedicines|July 27, 2024
Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to SexSimone Lasagni, Rosina Maria Critelli, Fabiola Milosa, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 11, 2002
Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantationAntonella Grottola, Paola Buttafoco, Maria Grazia Del Buono, et al.
Infection|November 4, 2017
Current and future challenges in HCV: insights from an Italian experts panelMassimo Andreoni, Sergio Babudieri, Savino Bruno, et al.
Journal of Hepatology|January 15, 2018
Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosisLaura Turco, Guadalupe Garcia-Tsao, Ilenia Magnani, et al.
Stem Cell Research & Therapy|February 22, 2023
Flow-dependent shear stress affects the biological properties of pericyte-like cells isolated from human dental pulpGiulia Bertani, Rosanna Di Tinco, Laura Bertoni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 26, 2020
HCV cirrhotic patients treated with direct-acting antivirals: Detection of tubular dysfunction and resolution after viral clearanceElisa Biliotti, Donatella Palazzo, Francesca Tinti, et al.
Critical Reviews in Oncology/Hematology|December 26, 2024
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantationLorenza Di Marco, Adriana Romanzi, Alessandra Pivetti, et al.
Hepatology Communications|September 14, 2023
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective studyErica Villa, Rossella Donghia, Valentina Baldaccini, et al.
Pageof 15